Ryo Utsunomiya

Ryo Utsunomiya

Auto-generated profile, based on publicly available information

Ryo Utsunomiya

Department of Dermatology Ehime University Graduate School of Medicine Ehime Japan

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 January 2022 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
XDXiuju Dai
Xiuju Dai
JMJun Muto
Jun Muto
KSKen Shiraishi
Ken Shiraishi
RURyo Utsunomiya
Ryo Utsunomiya
HMHideki Mori
Hideki Mori
KSKoji Sayama
Koji Sayama

1 November 2021 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
XDXiuju Dai
Xiuju Dai
RURyo Utsunomiya
Ryo Utsunomiya
KSKen Shiraishi
Ken Shiraishi
HMHideki Mori
Hideki Mori
JMJun Muto
Jun Muto
KSKoji Sayama
Koji Sayama


22 April 2022 in European Journal of Immunology
Verified
Journal Article
Closed access
XDXiuju Dai
Xiuju Dai
MMMasamoto Murakami
Masamoto Murakami
KSKen Shiraishi
Ken Shiraishi
JMJun Muto
Jun Muto
MTMikiko Tohyama
Mikiko Tohyama
KSKoji Sayama
Koji Sayama

13 May 2018 in Experimental Dermatology
Verified
Journal Article
Open access
PDF file
RURyo Utsunomiya
Ryo Utsunomiya
XDXiuju Dai
Xiuju Dai
MMMasamoto Murakami
Masamoto Murakami
KMKana Masuda
Kana Masuda
HOHidenori Okazaki
Hidenori Okazaki
KSKoji Sayama
Koji Sayama
Epidermal keratinocytes initiate skin inflammation by activating immune cells. The skin barrier is disrupted in atopic dermatitis (AD) and epidermal keratinocytes can be exposed to environmental stimuli, such as house dust mite (HDM) allergens. We showed previously thatHDMallergens activate theNLRP3 inflammasome of keratinocytes, thereby releasing pro‐inflammatory cytokines. Heparinoid is an effective moisturizer for atopic dry skin. However, a recent report showed that heparinoid treatment can improve inflammation of lichen planus. Therefore, we hypothesized that it acts on epidermal keratinocytes not only as a moisturizer, but also as a suppressant of the triggers of skin inflammation. We found thatHDMallergen‐induced interleukin (IL)‐1β release from keratinocytes was inhibited significantly by heparinoid pretreatment without affecting cell viability. However, heparinoid did not affect caspase‐1 release, suggesting that heparinoid did not affectHDMallergen‐induced inflammasome activation. Heparinoid treatment not only decreased intracellular levels of pro‐IL‐1β, but also suppressedIL‐1β messengerRNA(mRNA) expression in keratinocytes. Among the intracellular signalling pathways, the activation of extracellular signal‐regulated kinase and p38 pathways, which are required forIL‐1β expression in keratinocytes, was inhibited by heparinoid treatment. The inhibitory effect of heparinoid onIL‐1βmRNAexpression was also confirmed with living skin equivalents. Our results demonstrated that heparinoid suppresses the initiation of keratinocyte‐mediated skin inflammation.